Patient Guide: IO102-IO103 in Combination With Pembrolizumab as First-line Treatment for Patients With Metastatic NSCLC, SCCHN, or mUBC

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 21 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT05077709
Status: ACTIVE_NOT_RECRUITING
Condition: Lung Cancer Non Small Cell, Head and Neck Squamous Cell Carcinoma, Urothelial Carcinoma Bladder
Phase: PHASE2

Find a Study Location Near You

This study is available at 21 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Duarte, California
  • Sacramento, California
  • San Diego, California
  • • And 18 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily